Details
Stereochemistry | RACEMIC |
Molecular Formula | C7H10N2O4 |
Molecular Weight | 186.1653 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(CC(N)C(O)=O)C(=O)NO1
InChI
InChIKey=UUDAMDVQRQNNHZ-UHFFFAOYSA-N
InChI=1S/C7H10N2O4/c1-3-4(6(10)9-13-3)2-5(8)7(11)12/h5H,2,8H2,1H3,(H,9,10)(H,11,12)
Molecular Formula | C7H10N2O4 |
Molecular Weight | 186.1653 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/6101908
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6101908
(±)-α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) is a selective agonist of AMPA subtype of glutamate receptors. It is used in biological studies as an experimental tool.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2096670 Sources: https://www.ncbi.nlm.nih.gov/pubmed/6101908 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6170075
in rats (microinjected into the lateral brain ventricle): (α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) produced generalized myoclonic seizures, short lasting hypoactivity followed by hyperactivity and hyperthermia when low doses were injected (0.25-1.0 microgram). When AMPA was injected at higher doses (1.5-5.0 microgram) it produced generalized myoclonic seizures, a hypoactive phase and hypothermia rapidly followed by hyperthermia
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6125564
Binding of [3H]AMPA (α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) to rat brain membranes was investigated. Computer-aided Scatchard analysis of the binding data, as determined by using L-glutamic acid (L-GLU) to define nonspecific binding, suggested the presence of two independent binding sites, with KDS of 9 and 2440 nM, respectively. Additional freezing, thawing and washing sequences gave membranes with only one binding site, with a KD of 278 nM. [3H]AMPA binding exhibited the highest level in striatal membranes.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:35:10 GMT 2023
by
admin
on
Sat Dec 16 08:35:10 GMT 2023
|
Record UNII |
J090588E6X
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
J090588E6X
Created by
admin on Sat Dec 16 08:35:10 GMT 2023 , Edited by admin on Sat Dec 16 08:35:10 GMT 2023
|
PRIMARY | |||
|
DTXSID20868301
Created by
admin on Sat Dec 16 08:35:10 GMT 2023 , Edited by admin on Sat Dec 16 08:35:10 GMT 2023
|
PRIMARY | |||
|
1221
Created by
admin on Sat Dec 16 08:35:10 GMT 2023 , Edited by admin on Sat Dec 16 08:35:10 GMT 2023
|
PRIMARY | |||
|
28812
Created by
admin on Sat Dec 16 08:35:10 GMT 2023 , Edited by admin on Sat Dec 16 08:35:10 GMT 2023
|
PRIMARY | |||
|
77521-29-0
Created by
admin on Sat Dec 16 08:35:10 GMT 2023 , Edited by admin on Sat Dec 16 08:35:10 GMT 2023
|
PRIMARY | |||
|
m1845
Created by
admin on Sat Dec 16 08:35:10 GMT 2023 , Edited by admin on Sat Dec 16 08:35:10 GMT 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
POSITIVE ALLOSTERIC MODULATOR->TARGET |
|
||
|
TARGET -> AGONIST |
|
||
|
LABELED -> NON-LABELED |
|